These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23860225)
1. Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of pancreatic cancer. Yang SH; Hsu CH; Lee JC; Tien YW; Kuo SH; Cheng AL Oncology; 2013; 85(2):86-94. PubMed ID: 23860225 [TBL] [Abstract][Full Text] [Related]
2. Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. Maréchal R; Bachet JB; Calomme A; Demetter P; Delpero JR; Svrcek M; Cros J; Bardier-Dupas A; Puleo F; Monges G; Hammel P; Louvet C; Paye F; Bachelier P; Le Treut YP; Vaillant JC; Sauvanet A; André T; Salmon I; Devière J; Emile JF; Van Laethem JL Clin Cancer Res; 2015 Mar; 21(5):1215-24. PubMed ID: 25552484 [TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549 [TBL] [Abstract][Full Text] [Related]
4. IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer. Song Y; Ji B; Jiang CX; Chen ZM; Yao NH; Mukaida N; Huang H Pathol Res Pract; 2019 Dec; 215(12):152650. PubMed ID: 31585811 [TBL] [Abstract][Full Text] [Related]
5. Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling Pathway. Zhuang L; Yao Y; Peng L; Cui F; Chen C; Zhang Y; Sun L; Yu Q; Lin K Dig Dis Sci; 2022 Aug; 67(8):3773-3782. PubMed ID: 34623580 [TBL] [Abstract][Full Text] [Related]
6. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. Drouillard A; Puleo F; Bachet JB; Ouazzani S; Calomme A; Demetter P; Verset G; Van Laethem JL; Maréchal R Br J Cancer; 2016 Nov; 115(10):1245-1252. PubMed ID: 27755532 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Wang W; Reiser-Erkan C; Michalski CW; Raggi MC; Quan L; Yupei Z; Friess H; Erkan M; Kleeff J Biochem Biophys Res Commun; 2010 Oct; 401(3):422-8. PubMed ID: 20863812 [TBL] [Abstract][Full Text] [Related]
8. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial. McAllister F; Pineda DM; Jimbo M; Lal S; Burkhart RA; Moughan J; Winter KA; Abdelmohsen K; Gorospe M; Acosta Ade J; Lankapalli RH; Winter JM; Yeo CJ; Witkiewicz AK; Iacobuzio-Donahue CA; Laheru D; Brody JR Cancer Biol Ther; 2014 Jun; 15(6):688-98. PubMed ID: 24618665 [TBL] [Abstract][Full Text] [Related]
9. P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment. Striefler JK; Sinn M; Pelzer U; Jühling A; Wislocka L; Bahra M; Sinn BV; Denkert C; Dörken B; Oettle H; Riess H; Bläker H; Lohneis P Pathol Res Pract; 2016 Aug; 212(8):726-34. PubMed ID: 27461834 [TBL] [Abstract][Full Text] [Related]
10. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249 [TBL] [Abstract][Full Text] [Related]
11. SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Sinn M; Sinn BV; Striefler JK; Lindner JL; Stieler JM; Lohneis P; Bischoff S; Bläker H; Pelzer U; Bahra M; Dietel M; Dörken B; Oettle H; Riess H; Denkert C Ann Oncol; 2014 May; 25(5):1025-32. PubMed ID: 24562449 [TBL] [Abstract][Full Text] [Related]
12. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts. Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568 [TBL] [Abstract][Full Text] [Related]
13. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer. Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472 [TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype. Li Y; Yang W; Yang Q; Zhou S Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725 [TBL] [Abstract][Full Text] [Related]
15. Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer. Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Cui QC; Shi J; Wang TX; You L; Shu H World J Surg; 2013 Jul; 37(7):1688-94. PubMed ID: 23568245 [TBL] [Abstract][Full Text] [Related]
16. Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway. Wang TP; Hsu SH; Feng HC; Huang RF Carcinogenesis; 2012 Jun; 33(6):1158-68. PubMed ID: 22461522 [TBL] [Abstract][Full Text] [Related]
17. [The inhibition of the Sonic Hedgehog (SHh) pathway improves the effects of chemotherapy in a model of ductal carcinoma of the pancreas in mice]. Larsen CJ Bull Cancer; 2009 Sep; 96(9):829. PubMed ID: 19810163 [No Abstract] [Full Text] [Related]
18. High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma. Xu X; Wang Y; Chen J; Ma H; Shao Z; Chen H; Jin G J Gastrointest Surg; 2012 Aug; 16(8):1493-8. PubMed ID: 22639377 [TBL] [Abstract][Full Text] [Related]
19. Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma. Zhang JJ; Wu HS; Wang L; Tian Y; Zhang JH; Wu HL World J Gastroenterol; 2010 Jun; 16(23):2881-8. PubMed ID: 20556833 [TBL] [Abstract][Full Text] [Related]
20. Cancer. Breaching the cancer fortress. Olson P; Hanahan D Science; 2009 Jun; 324(5933):1400-1. PubMed ID: 19520948 [No Abstract] [Full Text] [Related] [Next] [New Search]